{
  "slug": "creatine-cognition",
  "round": 2,
  "group": 7,
  "date": "2026-10-14",
  "authoring_model": "Sol 6.1",
  "adversarial_reviewer": "Claude Opus 5.5 (Anthropic)",
  "canonical_path": "hsef_v53_traffic_first_five_2026-10-12/creatine-cognition/creatine-cognition.review.md",
  "level_before": "Ε",
  "level_after": "Ε",
  "confidence_before": "Moderate",
  "confidence_after": "Moderate",
  "role_before": "reinforcing / stabilizing factor",
  "role_after": "reinforcing / stabilizing factor",
  "pmids_checked": 61,
  "pmids_failed": 0,
  "retractions_or_eoc_found": 0,
  "claims_spot_checked": 15,
  "validator": {
    "before": "FAIL — 1 fail, 0 warn, 33 pass (v5.lay_summary)",
    "after": "FAIL — 1 fail, 0 warn, 33 pass (v5.lay_summary)",
    "note": "Validator 2.4 enforces the v5.4 lay-summary requirement against a v5.3 package; unchanged by this pass."
  },
  "findings": [
    {
      "id": "AR-1",
      "severity": "Major",
      "type": "rendering_defect",
      "location": [
        "prose review, throughout",
        "score card, throughout"
      ],
      "original": "141 numeral-adjacent fused tokens, e.g. includes61 / preregistered123-person / at5g/day / no24week / sixweeks / reducedATP / olderwomen",
      "corrected": "spaces or hyphens restored",
      "evidence": "Known 'randomize3808' rendering-defect class at scale. Study identifiers, DOIs, PMC/PMID/NCT tokens, rubric filenames and subclaim labels were excluded from the substitution and verified unchanged afterwards. No wording or claim was altered."
    },
    {
      "id": "AR-2",
      "severity": "Major",
      "type": "momentum_boilerplate",
      "location": [
        "AT A GLANCE table",
        "Final score, causal direction and M/S/D",
        "scorecard extended_scoring_MSD.momentum"
      ],
      "original": "Decisive work underway",
      "corrected": "Mechanistic only",
      "evidence": "The three named works (PMIDs 42075005, 40854087, 42578920) are completed published reports in new populations, none of which supplies the review's own quoted Zeta requirement of independent multi-site preregistered replication with blinding-integrity reporting plus a mechanism-narrowing result. The Stability entry already states that no verified pending result fixing the next threshold was identified.",
      "level_impact": "none (M/S/D modify no letter)"
    },
    {
      "id": "AR-3",
      "severity": "Minor",
      "type": "missing_required_artifact",
      "location": [
        "Final score, causal direction and M/S/D, Divergence line"
      ],
      "original": "Divergence: Contested. No manufactured field consensus or arithmetic gap.",
      "corrected": "Same value, now naming the two conflicting framings that make a single implied level indefensible, matching the score card's implied_level_basis field.",
      "evidence": "Divergence requires a checkable artifact; the prose asserted only the absence of one while the score card carried the reasoning."
    },
    {
      "id": "AR-4",
      "severity": "Minor",
      "type": "confidence_rationale",
      "location": [
        "scorecard final_score.confidence_rationale"
      ],
      "original": "density, heterogeneous controls and incomplete access set the confidence, not correctness.",
      "corrected": "evidence density, independent replication and heterogeneity of controls set the confidence; access depth and belief in correctness do not.",
      "evidence": "The framework ties confidence to evidence density and reproducibility; the boilerplate rationale named \"incomplete access\" as a determinant. Rewritten to rest on density, replication and heterogeneity. Band re-tested against both band texts and unchanged. Moderate remains correct under the framework's Moderate text."
    }
  ],
  "rejected_findings": [
    {
      "id": "RJ-1",
      "claim": "The headline should be Delta (one robust stress study) or Zeta (replication plus mechanism).",
      "resolution": "Rejected both. Delta fails because the context boundary is mapped rather than untested, which the framework says means Epsilon. Zeta fails the shared-failure independence test: the positive human results are one oral-supplement modality, spectroscopy is target engagement, and congenital/animal transport work is a different scope."
    },
    {
      "id": "RJ-2",
      "claim": "Aggregation misapplied.",
      "resolution": "Rejected. Primary-subclaim pre-registered with SC2 named; alternatives reported (weakest-link Gamma, scope-matched Epsilon); SC2's scope matches the central claim's scope."
    },
    {
      "id": "RJ-3",
      "claim": "Fourteen reference years disagree with PubMed.",
      "resolution": "Rejected; all are print-versus-e-pub differences of one year."
    },
    {
      "id": "RJ-4",
      "claim": "Collective-author leading-comma defect, empty DOI fields, retrieval handles or 'PMID not supplied' strings present.",
      "resolution": "Rejected; screened and none present."
    },
    {
      "id": "RJ-5",
      "claim": "Routing a nutrition claim through rubric07 and rubric06 is a scoring error.",
      "resolution": "Rejected; the adaptation is declared and the literal criteria are quoted unchanged, which is the framework's prescribed response to a rubric gap."
    },
    {
      "id": "RJ-6",
      "claim": "Lead-reported artifacts: nominal printed as best-supported rival, false approval boilerplate, reviewer-notes contradiction, confidence band wrong.",
      "resolution": "All screened and rejected for this case. models_evaluated[0] is the rank-1 non-nominal model, so the rival label is correct; this is not a revised edition, so no approval or provenance boilerplate applies; and the band was re-tested against both framework texts with Moderate standing."
    }
  ],
  "attribution_audit": {
    "citation_inversions_found": 0,
    "population_or_dose_errors": 0,
    "checked": [
      "14561278 Rae 2003: 45 vegetarians, 5 g/day, six weeks, BDS and RAPM gains",
      "37968687 123-person preregistered crossover: BDS borderline, RAPM null, no vegetarian advantage",
      "16416332 / 17046034 McMorris: benefit confined to complex central-executive tasks",
      "25632150 hypoxia: attention restored, brain creatine +9.2%",
      "18579168 rested young adults: comprehensive null",
      "37759877 dose-response: no cognition or PFC oxygenation effect",
      "24098469 older women, four arms of 14, 24 weeks: no cognitive effect; training improved mood and strength",
      "10484486 regionally dependent, reversible brain-creatine rise after 4 weeks",
      "17185404 PCr/ATP rise driven largely by falling ATP, not a uniform ATP boost",
      "21118604 128 young women, 20 g for 5 days: vegetarian-specific memory gain, fluency and vigilance null",
      "40854087 36 perimenopausal/menopausal women, three creatine formulations vs placebo",
      "42578920 middle-aged adults, findings explicitly exploratory",
      "40395689 single-arm 20-patient Alzheimer pilot",
      "41737290 bioenergetic report from the same NCT05383833 cohort",
      "40520504 hemispheric reanalysis of the same 15-person dataset as 38418482"
    ]
  },
  "residual_limitations": "The same builder defect produced word-to-word fusions with no numeral anchor (e.g. wellpowered, lowerbrainstores, restedomnivoretrial, samepersonbrainmeasurement, codedcreatine, andwithouttraining), concentrated in the evidence cards, reconciliation records and timeline. These cannot be repaired by exact string substitution without risking a change of meaning and are referred to the package builder.",
  "propagation_strings_for_lead": [
    {
      "file_class": "package-level (OVERVIEW.md, READER.html, EDITORIAL_HANDOFF.md, BATCH_COMPLETION.json)",
      "old": "Decisive work underway",
      "new": "Mechanistic only",
      "scope": "the creatine-cognition momentum field only"
    },
    {
      "file_class": "package-level renderings of this review's prose",
      "old": "any AR-1 fused token (e.g. 'includes61', 'preregistered123-person', 'olderwomen')",
      "new": "re-render from the corrected review rather than patching individually"
    }
  ],
  "approval": "Approved as revised. — Claude Opus 5.5 (Anthropic), 2026-10-14.",
  "findings_major": 2,
  "findings_minor": 2,
  "findings_editorial": 0,
  "rejected_count": 6,
  "lead_reported_artifacts_checked": [
    "false approval boilerplate (revised editions only)",
    "confidence band set from access depth",
    "renderer bug printing the nominal as best-supported rival",
    "reviewer-notes / provenance contradiction"
  ],
  "lead_policy_confidence_band": {
    "recorded": "2026-10-14, lead adjudication",
    "step_1": "Strike access depth as a confidence determinant everywhere; it is neither evidence density nor reproducibility and never justifies a band.",
    "step_2": "Re-derive the band from what remains. Raise it only if access depth was the sole reason holding it down and the cited evidence meets the High text. Substantive evidence-quality or reproducibility concerns documented in the review (indirect effects, incomplete washout, residual confounding of the mechanism, reporter rather than endogenous readouts) are valid determinants and the band stands.",
    "principle": "A reviewer's uncertainty about the evidence is a legitimate reason for Moderate; a reviewer's uncertainty about their own reading access is not.",
    "precedents": "hiv-aids raised Moderate to High (invalid reason and nothing else); 3d-genome-regulation stays Moderate (real scientific reservations recorded in its own text). The two are consistent.",
    "reviewer_position": "Agreed; this is the distinction applied in this pass.",
    "applied_here": "Step 1 applied (rationale rewritten under AR-4). Step 2: band stands at Moderate on valid determinants — the largest preregistered trial conflicts with the early large effect and methodological heterogeneity is substantial, which is the Moderate text, not access depth."
  }
}